Literature DB >> 12813055

Signaling role for phospholipase C gamma 2 in platelet glycoprotein Ib alpha calcium flux and cytoskeletal reorganization. Involvement of a pathway distinct from FcR gamma chain and Fc gamma RIIA.

Pierre Mangin1, Yuping Yuan, Isaac Goncalves, Anita Eckly, Monique Freund, Jean-Pierre Cazenave, Christian Gachet, Shaun P Jackson, François Lanza.   

Abstract

Interaction of the platelet GPIb-V-IX complex with surface immobilized von Willebrand factor (vWf) is required for the capture of circulating platelets and their ensuing activation. In previous work, it was found that GPIb/vWf-mediated platelet adhesion triggers Ca2+ release from intracellular stores, leading to cytoskeletal reorganization and filopodia extension. Despite the potential functional importance of GPIb-induced cytoskeletal changes, the signaling mechanisms regulating this process have remained ill-defined. The studies presented here demonstrate an important role for phospholipase C (PLC)-dependent phosphoinositide turnover for GPIb-dependent cytoskeletal remodeling. This is supported by the findings that the vWf-GPIb interaction induced a small increase in inositol 1,4,5-triphosphate (IP3) and that treating platelets with the IP3 receptor antagonist APB-2 or the PLC inhibitor U73122 blocked cytosolic Ca2+ flux and platelet shape change. Normal shape change was observed in G alpha q-/- mouse platelets, excluding a role for PLC beta isoforms in this process. However, decreased shape change and Ca2+ mobilization were observed in mice lacking PLC gamma 2, demonstrating that this isotype played an important, albeit incomplete, role in GPIb signaling. The signaling pathways utilized by GPIb involved one or more members of the Src kinase family as platelet shape change and Ca2+ flux were inhibited by the Src kinase inhibitors PP1 and PP2. Strikingly, shape change and Ca2+ release occurred independently of immunoreceptor tyrosine-based activation motif (ITAM)-containing receptors, because these platelet responses were normal in human platelets treated with the anti-Fc gamma RIIA blocking monoclonal antibody IV.3 and in mouse platelets deficient in the FcR gamma chain. Taken together, these studies define an important role for PLC gamma 2 in GPIb signaling linked to platelet shape change. Moreover, they demonstrate that GPIb-dependent calcium flux and cytoskeletal reorganization involves a signaling pathway distinct from that utilized by ITAM-containing receptors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12813055     DOI: 10.1074/jbc.M302333200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii.

Authors:  Ciara Keane; Helen Petersen; Kieran Reynolds; Debra K Newman; Dermot Cox; Howard F Jenkinson; Peter J Newman; Steven W Kerrigan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

Review 2.  Involvement of Fc receptors in disorders of the central nervous system.

Authors:  Eitan Okun; Mark P Mattson; Thiruma V Arumugam
Journal:  Neuromolecular Med       Date:  2009-10-21       Impact factor: 3.843

3.  Aged garlic extract suppresses platelet aggregation by changing the functional property of platelets.

Authors:  Naoaki Morihara; Atsuko Hino
Journal:  J Nat Med       Date:  2016-10-20       Impact factor: 2.343

Review 4.  New Concepts and Mechanisms of Platelet Activation Signaling.

Authors:  Brian Estevez; Xiaoping Du
Journal:  Physiology (Bethesda)       Date:  2017-03

Review 5.  A2 adenosine receptors and vascular pathologies.

Authors:  Hillary A Johnston-Cox; Milka Koupenova; Katya Ravid
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-04       Impact factor: 8.311

6.  Platelet integrin α6β1 controls lung metastasis through direct binding to cancer cell-derived ADAM9.

Authors:  Elmina Mammadova-Bach; Paola Zigrino; Camille Brucker; Catherine Bourdon; Monique Freund; Adèle De Arcangelis; Scott I Abrams; Gertaud Orend; Christian Gachet; Pierre Henri Mangin
Journal:  JCI Insight       Date:  2016-09-08

7.  The heptapeptide LSARLAF mediates platelet activation through phospholipase Cgamma2 independently of glycoprotein IIb-IIIa.

Authors:  Andrew C Pearce; Peter Wonerow; Stuart J Marshall; Jon Frampton; T Kent Gartner; Steve P Watson
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

8.  Impaired alpha(IIb)beta(3) integrin activation and shear-dependent thrombus formation in mice lacking phospholipase D1.

Authors:  Margitta Elvers; David Stegner; Ina Hagedorn; Christoph Kleinschnitz; Attila Braun; Marijke E J Kuijpers; Michael Boesl; Qin Chen; Johan W M Heemskerk; Guido Stoll; Michael A Frohman; Bernhard Nieswandt
Journal:  Sci Signal       Date:  2010-01-05       Impact factor: 8.192

9.  Glycoproteins VI and Ib-IX-V stimulate tyrosine phosphorylation of tyrosine kinase Syk and phospholipase Cgamma2 at distinct sites.

Authors:  Katsue Suzuki-Inoue; Jonathan I Wilde; Robert K Andrews; Jocelyn M Auger; Reuben P Siraganian; Fujio Sekiya; Sue Goo Rhee; Steve P Watson
Journal:  Biochem J       Date:  2004-03-15       Impact factor: 3.857

10.  Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation.

Authors:  Ye-Ming Lee; Wei-Fan Chen; Duen-Suey Chou; Thanasekaran Jayakumar; Ssu-Yu Hou; Jie-Jen Lee; George Hsiao; Joen-Rong Sheu
Journal:  J Biomed Sci       Date:  2010-06-04       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.